Breast cancer

Vaginal ring or testosterone cream could reduce sexual dysfunction in breast cancer patients

Use of a vaginal ring or intravaginal testosterone cream (IVT) reduced vaginal dryness and sexual dysfunction in post-menopausal women with breast cancer receiving aromatase inhibitors (AIs) without showing persistent elevation in estradiol levels, research has shown. …

Tamoxifen effectiveness not impaired by SSRIs

Researchers found no difference in mortality rates in women taking tamoxifen with paroxetine or fluoxetine compared with patients taking tamoxifen with other SSRIs.…

Breast cancer drug that extends life given nod by European regulator

A new breast cancer drug that could delay the progression of the disease for an extra ten months has been recommended for approval by the European Medicines Agency.…

Patient drug expectations influence side effects, breast cancer study finds

Women expecting side effects from taking some breast cancer drugs are more likely to experience them than women with more optimistic expectations. …

Breast cancer risk associated with hormone replacement therapy has been underestimated

Risk of breast cancer in women taking combined menopausal hormone therapy is three times higher than in non-users, study finds.…

Study finds no link between IVF and breast cancer risk

Researchers have found no increased risk of breast cancer among women who have undergone IVF, even after more than 20 years of follow up. …

Calcium channel blockers not linked to breast cancer risk

Analysis of data on 50,757 women conflicts with previous research that suggested calcium channel blockers increase breast cancer risk…

Bone drug could help prevent breast cancer in BRCA1 carriers

Blocking RANK ligand with denosumab reduced proliferation of breast cells from women at high genetic risk of breast cancer.…

Lowering cholesterol could help combat treatment resistant breast cancer

Blocking key enzymes in the cholesterol biosynthesis pathway reduced proliferation of cancer cells by 30–50%.…

Ten years of hormone therapy cuts breast cancer recurrence

Post-menopausal women with hormone receptor-positive early-stage breast cancer who take hormone therapy for ten years reduce the risk of their cancer recurring by 34% compared with those who take it for five years, according to the results of a clinical trial.…